Aims and Scope of Molecular Pain
Molecular Pain is a peer-reviewed open access medical journal covering all aspects of research on pain. It was established in 2005 and is published by BioMed Central. The editors-in-chief are Jianguo Gu (University of Alabama at Birmingham) and Min Zhuo (University of Toronto), who was also the founding editor of the journal. It is sponsored by the University of Cincinnati College of Medicine. Less
Key Metrics
CiteScore 

5.6
Impact Factor 

< 5
SJR 

Q3Molecular Medicine

SNIP 

0.85
Recommended pre-submission checks
Powered by 

Topics Covered on Molecular Pain
Molecular Pain Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS INC |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2500 |
| Publication Time | 11 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2005 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Molecular Pain ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Molecular Pain
EXPRESS: Effects of cooling on the excitability of trigeminal Aβ-afferent nociceptors in mice: involvement of temperature-sensitive K2P channels.
- 19 Jun 2026
- Molecular pain
EXPRESS: Assessing Pain Sensitivity with COX-2 Biomarkers: A Novel Approach in Healthy Volunteers.
- 5 Jun 2026
- Molecular pain
Dezocine alleviates cancer-induced bone pain and suppresses intraosseous tumor growth in renal cell carcinoma via the NAMPT/NAD+ axis
- 5 Jun 2026
- Molecular Pain
EXPRESS: Precursor signaling redefined: proneurotrophin-3, not neurotrophin-3, in primary sensory neurons as an instigator in neuropathic pain.
- 5 Jun 2026
- Molecular pain
EXPRESS: Transcriptome profiling and experimental validation identify FOS, RAC2, and TYROBP as potential biomarkers for Fu's subcutaneous needling in neuropathic pain treatment.
- 3 Jun 2026
- Molecular pain
EXPRESS: RIN1 inhibited TRPV1-dependent pain sensitization in a mouse model of bone cancer pain.
- 26 May 2026
- Molecular pain
EXPRESS: Effects of cooling on the excitability of trigeminal Aβ-afferent nociceptors in mice: involvement of temperature-sensitive K2P channels.
- 19 Jun 2026
- Molecular pain
EXPRESS: Assessing Pain Sensitivity with COX-2 Biomarkers: A Novel Approach in Healthy Volunteers.
- 5 Jun 2026
- Molecular pain
Dezocine alleviates cancer-induced bone pain and suppresses intraosseous tumor growth in renal cell carcinoma via the NAMPT/NAD+ axis
- 5 Jun 2026
- Molecular Pain
EXPRESS: Precursor signaling redefined: proneurotrophin-3, not neurotrophin-3, in primary sensory neurons as an instigator in neuropathic pain.
- 5 Jun 2026
- Molecular pain
EXPRESS: Transcriptome profiling and experimental validation identify FOS, RAC2, and TYROBP as potential biomarkers for Fu's subcutaneous needling in neuropathic pain treatment.
- 3 Jun 2026
- Molecular pain
EXPRESS: RIN1 inhibited TRPV1-dependent pain sensitization in a mouse model of bone cancer pain.
- 26 May 2026
- Molecular pain